Prosopagnosia as symptom of migraine with aura: a case report.
Sándor
P S
PS
Headache & Pain Unit, Neurology Department, University Hospital Zurich, Zurich, Switzerland. peter.sandor@usz.ch
Morath
G P
GP
Hess
K
K
Kaube
H
H
Agosti
R M
RM
Regard
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D020325:Migraine with Aura / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D009248:Nadolol / Q000627:therapeutic use; D020238:Prosopagnosia / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D005473:Fluoxetine; D009248:Nadolol; D017367:Selective Serotonin Reuptake Inhibitors